Skip to main content

Table 3 Univariate and multivariate analyses of prognostic factors for DFS in gastric cancer

From: LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling

Variable DFS
Univariate analysis Multivariate analysis
P value HR (95% CI) P value HR (95% CI)
Age (yr) 0.369 0.722 (0.355–1.470)   
  ≤ 50 vs > 50
Gender 0.784 1.092 (0.581–2.054)   
 Male vs female
Tumor diameter (cm) 0.001** 2.999 (1.612–5.577) 0.228 1.536 (0.765–3.086)
  ≤ 4 vs > 4
Tumor location 0.693 0.877 (0.457–1.681)   
 Up + Middle vs Down
Tumor differentiation 0.043* 1.895 (1.021–3.515) 0.353 1.361 (0.710–2.610)
 High + Middle vs Low
CEA (ng/ml) 0.135 1.755 (0.839–3.672)   
  ≤ 5 vs > 5
CA 19-9 (U/ml) 0.845 0.926 (0.429–2.000)   
  ≤ 37 vs > 37
HP infection 0.746 0.905 (0.494–1.658)   
 − vs + 
T stage 0.002** 3.270 (1.561–6.849) 0.724 0.842 (0.325–2.184)
 T1-2 vs T3-4
N stage  < 0.0001**** 7.548 (3.324–17.140) 0.017* 3.188 (1.235–8.230)
 N0 vs N1-3
HOXA-AS3 in tissues  < 0.0001**** 7.462 (3.420–16.283) 0.005** 4.014 (1.534–10.508)
 High vs Low
  1. *< 0.05; **< 0.01; ****< 0.0001